Fundraising Fox

Indevr

Boulder, US · Delaware corporation · 1 known investors

indevr.com ↗

InDevR develops and manufactures analytical instruments and assays for life science and clinical diagnostics applications, including its FluChip-8G influenza test that received 510(k) clearance. The company commercializes technologies translated from research, supported by government contracts and grants.

BiotechHardwareHealthtechMedical Devicesin /indevr-inc-@InDevR_Inc

Founders & leadership

MC
Michael ChangDirector
KR
Kathy RowlenCo-founder, Scientific Advisor (former CEO)
SR
Shannon RodriguezChief Operations Officer
LK
Laura KuckExecutive Officer
ED
Erica DawsonChief Technical Officer
CH
Craig HoechstetterChief Commercial Officer
GR
Glenn RockmanDirector

Investors · 1

Adjuvant CapitalNew York · $10M – $25M

Reported raises · per SEC filings

Form D private placements
▶$6MraisedJan 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ChangDirector
  • Shannon RodriguezExecutive Officer, Director, Promoter
  • Kathy RowlenExecutive Officer, Director, Promoter
  • Michael ReynierDirector
  • Erica DawsonExecutive Officer
Offering amount
$9M
Amount sold
$6M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedSep 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ChangDirector
  • Kathy RowlenExecutive Officer, Director, Promoter
  • Shannon RodriguezExecutive Officer, Director, Promoter
  • Laura KuckExecutive Officer
  • Erica DawsonExecutive Officer
  • Glenn RockmanDirector
Offering amount
$7M
Amount sold
$4M
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.